Kyowa Hakko USA is a biotechnology company located in New York, New York, specializing in the manufacturing of fermented amino acids and branded nutritional ingredients. Situated in the heart of Manhattan, the company focuses on producing high-quality bioactive compounds that support health and wellness across various applications. Their portfolio includes well-known ingredients such as Cognizin citicoline, Setria Glutathione, and Pantesin pantethine, each developed through advanced fermentation processes.
The company’s product range also features VELOX® Blend, which combines L-Citrulline and L-Arginine, along with IMMUSE™, a proprietary Lactococcus lactis strain Plasma ingredient. These offerings are designed to cater to the nutritional and pharmaceutical industries, providing foundational components for dietary supplements and functional foods. Kyowa Hakko USA emphasizes scientific research and innovation to ensure the efficacy and purity of its ingredients, supporting the development of health-enhancing products.
Located at 600 3rd Avenue on the 19th floor, Kyowa Hakko USA operates within a dynamic business environment that encourages collaboration with industry partners and customers. The company’s focus on biotechnology aligns with ongoing trends in health science and nutritional innovation, contributing to advancements in dietary supplementation and therapeutic support. As a division of a global enterprise, Kyowa Hakko USA benefits from extensive expertise in fermentation technology and ingredient development.
In addition to manufacturing, the company provides technical support and expertise to clients looking to integrate their ingredients into various formulations. By maintaining stringent quality control and leveraging cutting-edge biotechnology, Kyowa Hakko USA plays a critical role in the supply chain for nutritional ingredients in the New York region and beyond. Their presence in New York underscores the city’s growing importance as a hub for life sciences and biotechnology enterprises.
